Our Research
Autonomous diagnostic screening using retinal images
Our Mission
We're Building a Technology Platform to Enable Screening For a Broad Range of Diseases
.png)
Ocular Diseases Detection
Our autonomous screening detects 12 different sight-threatening indications, enabling early diagnosis, treatment and prevention. These conditions include glaucoma, AMD, DME, occlusions, hypertensive retinopathy, and papilledema.
.png)
Systemic Diseases Detection
Using simple retinal images, our system is able to detect systemic diseases, providing opportunities for early intervention and the potential prevention of serious, potentially life-threatening conditions. These conditions include diabetes, cardiovascular diseases, hypertension, intraocular cancer, and dementia (alpha).
.png)
Disease Prediction
Our novel AI model is capable of predicting disease onset before diagnosable symptoms manifest, offering patients an opportunity for early intervention and potential disease prevention. These conditions include localized and systemic conditions.
.png)
Diabetic Retinopathy
Diabetic retinopathy is a common complication of diabetes, and the leading cause of blindness in American working-age adults. It is caused by damage to the blood vessels in the retina due to prolonged high blood sugar levels and other risk factors. In early stages symptoms are often unrecognized, however when left undetected, it can cause blindness.
High blood sugar levels in patients with diabetes cause damage throughout the body, including to blood vessels in the retina, resulting in progressive loss of vision if left untreated. The risk for developing diabetic retinopathy increases with time and high blood sugar. Long periods of high blood sugar lead to accumulation of fluid in the blood vessels, causing blockages or leaks that affect vision.
Desktop
Handheld
>99%
Imageability
91.9%
Sensitivity
93.6%
Specificity
>99%
Imageability
93.0%
Sensitivity
91.4%
Specificity
.png)
Glaucoma
Glaucoma is the second most common cause of blindness worldwide. Our algorithm enables early detection and accessible screening, encouraging timely and effective treatment. Our results are also the first to show high agreement with eye doctors.
92.2%
Sensitivity
92.6%
Specificity
.png)
AMD
Age-related Macular Degeneration is an extremely common condition which impairs sharp central vision.
Our algorithm enables early detection, which can aid in dramatically slowing disease progression.
>92%
Sensitivity
>92%
Specificity
Ground Breaking Accuracy For A Broad Range Of Diseases
Diabetic Retinopathy
Best-in-class accuracy
Published results
Diabetic retinopathy is the leading cause of blindness in working-age adults in the US.
Our FDA-cleared technology enables accessible early detection, which can save the sight of millions.
Diabetic Retinopathy
Best-in-class accuracy
Published results
Diabetic retinopathy is the leading cause of blindness in working-age adults in the US.
Our FDA-cleared technology enables accessible early detection, which can save the sight of millions.
Glaucoma
Best-in-class accuracy
Published results
Glaucoma is the second most common cause of blindness worldwide.
​
Our algorithm enables early detection and accessible screening, encouraging timely and effective treatment. Our results are also the first to show high agreement with eye doctors.
​
Age-related macular degeneration (AMD)
Best-in-class accuracy
Publication coming soon
Age-related Macular Degeneration is an extremely common condition which impairs sharp central vision.
​
Our algorithm enables early detection, which can aid in dramatically slowing disease progression. Results for our best-in-class solution will be published imminently.
